ARTICLE | Clinical News
Letairis: Additional Phase IIIb/IV data
September 7, 2015 7:00 AM UTC
Gilead previously reported that the combination arm met the primary endpoint in the trial (see BioCentury, Nov. 10, 2014). An sNDA for the combination treatment to treat PAH is under FDA review with a...